Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma
Closed
Phase 2
This study is looking at a type of called tebentafusp. It is for people with melanoma of the skin (cutaneous), or of the eye (uveal), that:
have finished treatment, or are about to finish treatment
are at an increased risk of their melanoma coming back
Recruitment start: 1 August 2022
Recruitment end: 30 April 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Middleton
University of Oxford
Immunocore
Cancer Research UK Oxford Centre
NIHR Oxford Biomedical Research Centre
Last reviewed: 29 April 2025
CRUK internal database number: 19101
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
